Jim Cramer Expresses Disappointment Over Toll Brothers Outlook The Energy Report First and Goal Energy Markets at a Critical Juncture Gossamer Bio Investors Urged to Act Before Securities Class Action Deadline Rosen Law Firm Japan China Trade Chiefs Hold First Bilateral Chat at APEC Since Trade Dispute Apple Inc AAPL Identified as a LongTerm Focus Stock by Louis Navellier on Earnings Growth Prospects Reddit Shares Slide Nearly 6 After Meta Launches New Forum App Intensifying Competitive Pressure FBIOP Q4 2025 Earnings Preferred Stock Reports Negative EPS Surprise Amid No Revenue Disclosure Corteva Q1 2026 Earnings Strong Earnings Beat Driven by Operational Efficiency CRH Q1 2026 Earnings EPS Surprises to the Upside Amid Mixed Construction Demand LND Q1 2026 Earnings Negative EPS Reported Amid Challenging Agricultural Season ADT Q1 2026 Earnings Earnings Beat Estimates Despite Flat Revenue Disclosure Weatherford International WFRD Q1 2026 Earnings Strong EPS Beat of 391 Drives Positive Surprise Despite Modest Share Decline Almonty Industries ALM Holds Near Support as Price Declines Fractionally indie Semiconductor INDI Surges Over 15 as Bullish Momentum Builds Novartis NVS Holds Gains Near 151 as Pharmaceutical Sector Shows Stability Keros Therapeutics KROS Rises 196 Testing Key Resistance at 1202 Saratoga Investment Corp SAR Holds Steady at 2223 as Support and Resistance Levels Tighten Sacheerome Limited Shares Surge 218 from IPO Price as Profit Rises 78 DJCO Q4 2025 Earnings Strong EPS of 3061 Highlights Profitability Amidst No Revenue Disclosure Phillips 66 PSX Holds Near Flat as Trading Range Tightens AECOM ACM Edges Higher as Infrastructure Momentum Builds Otter Tail Corporation OTTR Edges Higher Amid Steady Support Key Resistance in Focus Oragenics Inc OGEN Slips Amid Low Volume Hovers Near Key Support Altisource Portfolio Solutions Warrants ASPSZ Edges Lower as Tight Trading Range Persists Seadrill SDRL Slips 13 as Offshore Drilling Stock Tests Key Support Levels DevvStream Corp DEVS Hovers Near Support at 012 as Low Volume Suggests Indecision Axsome Therapeutics Holds Near Resistance as Biotech Sector Shows Mixed Signals